Cornea News and Research

RSS

Carl Zeiss Meditec releases new software advances for the ATLAS® Corneal Topography System

New software advances for the ATLAS® Corneal Topography System were released today by Carl Zeiss Meditec during the American Academy of Optometry meeting in Orlando, Florida. Review Software and MasterFit II™ Contact Lens Software for the ATLAS corneal topography system are designed to make clinical data and images more accessible for eye care providers, while facilitating improved eye care diagnosis and treatment solutions for patients.

13 Nov 2009

AcuFocus Corneal Inlay: Will it improve near vision in patients with presbyopia?

The Cornea and Laser Eye Institute is participating in a research study to determine if an investigational corneal inlay can safely and effectively reduce the need for reading glasses. Dr. Peter Hersh, the study doctor, will perform the procedures.

6 Nov 2009

Multicenter study finds AMD patients can benefit from cataract surgery

This month's Ophthalmology, the journal of the American Academy of Ophthalmology (Academy) reports on a national study that finds cataract surgery is likely to benefit patients with age-related macular degeneration (AMD) at all stages of the disease, on a clinical trial showing that the steroid triamcinolone may be effective in advanced diabetic macular edema (DME) patients when standard treatment fails, and on the public's use of two Academy-sponsored online eye health forums.

2 Nov 2009

UT Southwestern ophthalmologist receives 2009 Castroviejo Medal

Dr. H. Dwight Cavanagh, vice chairman of ophthalmology at UT Southwestern Medical Center, has been named the 2009 recipient of the prestigious Castroviejo Medal, one of the top ophthalmology prizes in the world.

30 Oct 2009

CWRU grants licensing agreement to Bioptigen for FDOCT technology

Case Western Reserve University and University Hospitals Case Medical Center have granted to Bioptigen, of Research Triangle Park, N.C ., an exclusive intellectual property licensing agreement for Fourier domain optical coherence tomography (FDOCT), an imaging technology developed from research at the university's Department of Biomedical Engineering.

27 Oct 2009

Dr. Paul Cutarelli, the first ophthalmologist to implant an advanced nanoFLEX lens

A Denver ophthalmologist recently became the first in Colorado to implant a special type of lens during cataract surgery, raising the bar for patient care in the state while increasing the quality of life for his patients.

27 Oct 2009

Angiotech Pharmaceuticals launches the Tan EndoGlide Endothelium Insertion System in the U.S.

Angiotech Pharmaceuticals, Inc., today announced the commercial launch of the Tan EndoGlide(TM) Endothelium Insertion System in the United States. Angiotech holds exclusive U.S. distribution rights to market and distribute the Tan EndoGlide Endothelium Insertion System, which it obtained in a supply agreement with privately held Network Medical Products, Ltd. Angiotech will launch the product during the American Academy of Ophthalmology meeting, to be held in San Francisco, CA on October 24-27, 2009.

24 Oct 2009

New technique developed to transform regular body cells into artificial stem cells

Scientists have overcome a key barrier to the clinical use of stem cells with a technique which transforms regular body cells into artificial stem cells without the need for introducing foreign genetic materials, which could be potentially harmful. The research, published in STEM CELLS, suggests that cells taken from a patient's eye can be "reprogrammed" to replace or restore cells lost to degenerative diseases.

23 Oct 2009

VisionGraft Sterile Cornea allograft now available at Tissue Banks International

Tissue Banks International (TBI) has announced the availability of the VisionGraft Sterile Cornea, the nation's first sterile cornea allograft. The VisionGraft Sterile Cornea (patent pending) is an irradiated cornea for use in tectonic transplant procedures.

22 Oct 2009

VisionCare Ophthalmic Technologies to present on its implantable telescope technology

VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for individuals with age-related macular degeneration (AMD), today announced upcoming scientific and corporate presentations on its implantable telescope technology.

21 Oct 2009

Study to examine the impact of LASIK procedure on patients’ quality of life

The U.S. Food and Drug Administration today announced the launch of a collaborative study with the National Eye Institute and the U.S. Department of Defense to examine the potential impact on quality of life from Laser-Assisted In Situ Keratomileusis (LASIK), a surgical procedure that uses an eximer laser to permanently change the shape of the cornea.

19 Oct 2009

Lions Eye Institute for Transplant & Research to study vision impairment and blindness

Real-time biomedical studies of factors leading to vision impairment are now possible through the world's largest ocular research center at Lions Eye Institute for Transplant & Research.

8 Oct 2009

NEI awards Case Western Reserve $1.57M for bacterial keratitis research

Researchers at Case Western Reserve University School of Medicine have been awarded a $1.57 million renewal grant from the National Eye Institute (NEI) of the National Institutes of Health to continue their study of corneal infections, specifically, bacterial keratitis, associated with contact lens wear. The grant will extend the work initiated last year with the receipt of a $2.4 million, five-year grant from the NEI.

8 Oct 2009

World Sight Day to focus global attention on blindness and vision impairment

World Sight Day, celebrated on October 8th, is an annual day of awareness to focus global attention on blindness and vision impairment as a major public health issue. World Sight Day is coordinated by the International Agency for the Prevention of Blindness (IAPB) under the global initiative of VISION 2020. This year, the theme for World Sight Day is Gender and Eye Health.

8 Oct 2009

Promising alternative to use of live animals for drug testing

International Stem Cell Corporation, the first company to perfect a method of creating human “parthenogenetic” stem cells from unfertilized eggs, announces positive results of its collaboration with Absorption Systems to study ISCO’s stem-cell-derived human corneal tissue as an alternative to live animals for drug testing.

6 Oct 2009

Scientific Advisory Board to provide guidance to support the development of FST-100

Foresight Biotherapeutics announced today the formation of its scientific advisory board to provide guidance to the company for the development of it’s lead product FST-100, a novel formulation of dexamethasone that includes povidone-iodine. Foresight’s Scientific Advisory Board is comprised of leaders in the field of Ophthalmology.

1 Oct 2009

ORBIS' Childhood Blindness Initiative aims to develop 50 pediatric ophthalmology centers across India

ORBIS International's flagship Flying Eye Hospital arrived in Jaipur, India with its international team of volunteer eye care specialists and global sponsor Alcon, Inc. (NYSE: ACL), the world's leading eye care company.

1 Oct 2009

New device for identifying eye conditions in infants

Tell-tale signs of a condition that can blind premature babies are being seen for the first time using a new handheld device in a study at Duke University Medical Center.

22 Sep 2009

Successful eye surgery involves eyetooth implant in eye

Blind for nine years, Sharron “Kay” Thornton has just regained her sight through a first-in-the-U.S. surgical procedure at Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine. The procedure -- modified osteo-odonto-keratoprosthesis (MOOKP) -- implanted her eyetooth in her eye, as a base to hold a prosthetic lens.

17 Sep 2009

FDA approves Sirion's Zirgan for treating acute herpetic keratitis

Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has approved its New Drug Application for Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% as a treatment for acute herpetic keratitis (dendritic ulcers). The FDA granted orphan drug designation to Zirgan for this indication in April 2007.

17 Sep 2009

Cornea News and Research

Carl Zeiss Meditec releases new software advances for the ATLAS® Corneal Topography System

AcuFocus Corneal Inlay: Will it improve near vision in patients with presbyopia?

Multicenter study finds AMD patients can benefit from cataract surgery

UT Southwestern ophthalmologist receives 2009 Castroviejo Medal

CWRU grants licensing agreement to Bioptigen for FDOCT technology

Dr. Paul Cutarelli, the first ophthalmologist to implant an advanced nanoFLEX lens

Angiotech Pharmaceuticals launches the Tan EndoGlide Endothelium Insertion System in the U.S.

New technique developed to transform regular body cells into artificial stem cells

VisionGraft Sterile Cornea allograft now available at Tissue Banks International

VisionCare Ophthalmic Technologies to present on its implantable telescope technology

Study to examine the impact of LASIK procedure on patients’ quality of life

Lions Eye Institute for Transplant & Research to study vision impairment and blindness

NEI awards Case Western Reserve $1.57M for bacterial keratitis research

World Sight Day to focus global attention on blindness and vision impairment

Promising alternative to use of live animals for drug testing

Scientific Advisory Board to provide guidance to support the development of FST-100

ORBIS' Childhood Blindness Initiative aims to develop 50 pediatric ophthalmology centers across India

New device for identifying eye conditions in infants

Successful eye surgery involves eyetooth implant in eye

FDA approves Sirion's Zirgan for treating acute herpetic keratitis

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News